Skip to content

13F-HR filed by SAMSARA BIOCAPITAL, LLC

SAMSARA BIOCAPITAL, LLC filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-14, with 42 holding rows worth $520,276,874.

Accession
0001104659-24-118933
Filed
2024-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2024

A holdings report, 42 entries on the cover page, a total value of $520,276,874 stated on the cover page (in dollars after the unit check, H1), rows summing to $520,276,874 with VALUE read as dollars as filed, 13F file number 028-19375. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CARGO THERAPEUTICS INC COM14179K101Stock4,415,689$81,469,462dollars as filed
MINERALYS THERAPEUTICS INC603170101COM5,074,916$61,457,233dollars as filed
SCHOLAR ROCK HLDG CORP80706P103COM6,788,609$54,376,758dollars as filed
NEUROGENE INC64135M105COMMON STOCK1,267,790$53,196,468dollars as filed
ALUMIS INC022307102COM3,266,498$34,886,199dollars as filed
ARCELLX INC COMMON STOCK03940C100Stock353,641$29,532,560dollars as filed
LENZ THERAPEUTICS INC52635N103COM1,208,473$28,689,149dollars as filed
NKARTA INC65487U108COMMON STOCK3,768,035$17,031,518dollars as filed
CLIMB BIO INC28658R106COMMON STOCK2,609,114$13,280,390dollars as filed
AVADEL PHARMACEUTICALS PLCG29687103COM SHS967,527$12,689,117dollars as filed
ZYMEWORKS INC98985Y108COM1,000,000$12,550,000dollars as filed
ACELYRIN INC00445A100COM2,523,022$12,438,498dollars as filed
CONTINEUM THERAPEUTICS INC CL A21217B100Stock588,816$11,269,938dollars as filed
JASPER THERAPEUTICS INC471871202COM NEW584,642$10,997,116dollars as filed
ABIVAX SA-00370M103SPONSORED ADS850,000$9,792,000dollars as filed
RHYTHM PHARMACEUTICALS INC76243J105COM172,647$9,044,976dollars as filed
INOZYME PHARMA INC45790W108COM1,562,500$8,171,875dollars as filed
SUTRO BIOPHARMA INC869367102COM2,196,814$7,600,976dollars as filed
CYPHERPUNK TECHNOLOGIES INC52187K200COM NEW2,442,352$6,276,845dollars as filed
GOSSAMER BIO INC COM38341P102Stock6,130,268$6,046,896dollars as filed
VERONA PHARMA PLC925050106SPONSORED ADS195,225$5,616,623dollars as filed
TANGO THERAPEUTICS INC87583X109COM630,000$4,851,000dollars as filed
ARTIVA BIOTHERAPEUTICS INC04317A107COM291,666$4,506,240dollars as filed
SYROS PHARMACEUTICALS INC87184Q206COM NEW1,786,427$3,840,818dollars as filed
IO BIOTECH INC449778109COM3,640,015$3,822,016dollars as filed
VTV THERAPEUTICS INC918385204CL A NEW206,784$2,805,025dollars as filed
IMMATICS N.VN44445109SHS198,000$2,259,180dollars as filed
PRIME MEDICINE INC74168J101COM540,304$2,090,976dollars as filed
Day One Biopharmaceuticals Inc23954D109Common Stock147,319$2,052,154dollars as filed
TERNS PHARMACEUTICALS INC COM880881107Stock202,348$1,687,582dollars as filed
HILLEVAX INC43157M102COM799,274$1,406,722dollars as filed
JANUX THERAPEUTICS INC47103J105COM22,526$1,023,356dollars as filed
BICARA THERAPEUTICS INC055477103COM35,000$891,450dollars as filed
ACLARIS THERAPEUTICS INC COM00461U105Stock696,171$800,597dollars as filed
LYRA THERAPEUTICS INC55234L105COM2,780,261$714,527dollars as filed
BOLT BIOTHERAPEUTICS INC097702104COM1,049,153$679,851dollars as filed
VIRACTA THERAPEUTICS INC92765F108COM689,709$159,599dollars as filed
ALLAKOS INC01671P100COM172,089$112,409dollars as filed
KRONOS BIO INC50107A104COM78,131$78,123dollars as filed
ALLOVIR INC019818103COM82,336$66,569dollars as filed
NUVATION BIO INC67080N119WARR133,333$13,053dollars as filed
SURROZEN INC86889P117*W EXP 08/01/20399,999$1,030dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-24-118933this filing2024-11-14acceptance time not in the bulk data set